South Korea Neurovascular Devices Market Size & Outlook

The neurovascular devices market in South Korea is expected to reach a projected revenue of US$ 282.7 million by 2033. A compound annual growth rate of 6.6% is expected of South Korea neurovascular devices market from 2025 to 2033.
Revenue, 2024 (US$M)
$157.5
Forecast, 2033 (US$M)
$282.7
CAGR, 2025 - 2033
6.6%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea neurovascular devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea neurovascular devices market highlights

  • The South Korea neurovascular devices market generated a revenue of USD 157.5 million in 2024 and is expected to reach USD 282.7 million by 2033.
  • The South Korea market is expected to grow at a CAGR of 6.6% from 2025 to 2033.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device type in 2024.
  • Cerebral Embolization and Aneurysm Coiling Devices is the most lucrative device type segment registering the fastest growth during the forecast period.


Neurovascular devices market data book summary

Market revenue in 2024USD 157.5 million
Market revenue in 2033USD 282.7 million
Growth rate6.6% (CAGR from 2025 to 2033)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentCerebral Embolization and Aneurysm Coiling Devices
Historical data2021 - 2023
Base year2024
Forecast period2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp, Acandis GmbH, Spiegelberg, Zylox


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.1% of the global neurovascular devices market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Asia Pacific, Japan neurovascular devices market is projected to lead the regional market in terms of revenue in 2033.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 568.5 million by 2033.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 44.95% in 2024. Horizon Databook has segmented the South Korea neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2021 to 2033.


South Korea neurovascular devices market is anticipated to witness moderate growth over the forecast period due to increasing healthcare expenditure. For instance, the healthcare expenditure in South Korea was 4.84% in 2018, whereas in 2016, it was 4.33%.

Increase in healthcare expenditure may encourage new and key players to enter the market, thereby propelling the market growth. However, declining cases of acute ischemic stroke may negatively impact the market growth.

In addition, low adoption of technologically advanced products and lack of skilled professionals in the country may hinder the market growth over the forecast period. According to the National Center for Biotechnology Information (NCBI), in 2016, the incidence of intracranial aneurysm was around 52.2 per 100,000 populations and more than half of the people were diagnosed with unruptured brain aneurysm.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website
Zylox View profile 501-1000 Hangzhou, Zhejiang, China, Asia http://www.zyloxmedical.com/
Acandis GmbH View profile 251-500 Pforzheim, Baden-Wurttemberg, Germany, Europe https://www.acandis.com/start-1-en
Spiegelberg View profile 11-50 Hamburg, Hamburg, Germany, Europe https://www.spiegelberg.de/en/
Penumbra Inc View profile 4200 One Penumbra Place, Alameda, CA, United States, 94502 https://www.penumbrainc.com
MicroPort Scientific Corp View profile 8230 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 https://www.microport.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

South Korea neurovascular devices market size, by device type, 2021-2033 (US$M)

South Korea Neurovascular Devices Market Outlook Share, 2024 & 2033 (US$M)

South Korea neurovascular devices market size, by device type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online